SXTP · 60 Degrees Pharmaceuticals Inc
United States · RS rating 14 · As of 2026-11-03
| Price | 1.01 USD |
|---|---|
| 1-day change | +11.5% |
| RS rating (overall / 1M / 3M / 12M) | 14 / 12 / 35 / 9 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 26 / 10 / 32 |
| Industry group (rank) | Medical-Ethical Drugs (94) |
| EPS growth Q/Q | +29.7% |
| Sales growth Q/Q | -30.7% |
| Distance from 52-week high | +81.2% |
| Market cap (USD) | $4.5M |